This paper proposes and demonstrates an extended protocol for usability validation testing of medical devices” Schmettow et al (2017).
This paper proposes and demonstrates an extended protocol for usability validation testing of medical devices. A review of currently used methods for the usability evaluation of medical devices revealed two main shortcomings. Firstly, the lack of methods to closely trace the interaction sequences and derive performance measures. Secondly, a prevailing focus on cross-sectional validation studies, ignoring the issues of learnability and training. The U.S. Federal Drug and Food Administration’s recent proposal for a validation testing protocol for medical devices is then extended to address these shortcomings: (1) a novel process measure ‘normative path deviations’ is introduced that is useful for both quantitative and qualitative usability studies and (2) a longitudinal, completely within-subject study design is presented that assesses learnability, training effects and allows analysis of diversity of users.
ReTweet if useful… Protocol example for usability validation of medical devices https://ctt.ec/Wylms+ @ivteam #ivteam
A reference regression model is introduced to analyze data from this and similar studies, drawing upon generalized linear mixed-effects models and a Bayesian estimation approach. The extended protocol is implemented and demonstrated in a study comparing a novel syringe infusion pump prototype to an existing design with a sample of 25 healthcare professionals. Strong performance differences between designs were observed with a variety of usability measures, as well as varying training-on-the-job effects. We discuss our findings with regard to validation testing guidelines, reflect on the extensions and discuss the perspectives they add to the validation process.
Schmettow, M., Schnittker, R. and Schraagen, J.M. (2017) An extended protocol for usability validation of medical devices: research design and reference model. Journal of Biomedical Informatics. March 21st. .
Thank you to our partners for supporting IVTEAM